Stay updated on Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial

Sign up to get notified when there's something new on the Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Introduction of a new 'Study Status' item in the history and a new version entry (version 21) dated 2026-07-24. An older entry dated 2026-05-12 was removed.
    Difference
    0.3%
    Check dated 2026-08-24T17:08:36.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The study record history now includes a new revision v3.6.5 and removes the previous revision v3.6.4, indicating an update to the record.
    Difference
    0.1%
    Check dated 2026-08-10T10:28:59.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The History section now shows revision v3.6.4, replacing v3.6.3. This indicates a new version of the record/history was published, updating the page's underlying revision metadata.
    Difference
    0.1%
    Check dated 2026-07-27T05:55:05.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The revision label in the history table updates from v3.6.2 to v3.6.3, indicating a new revision of the study record.
    Difference
    0.1%
    Check dated 2026-07-05T11:46:50.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page history now lists Revision: v3.6.2, replacing v3.6.0. This reflects a small update to the page’s versioning rather than a change to the study data or visible content.
    Difference
    0.1%
    Check dated 2026-06-28T08:39:00.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The study record now indicates that no more participants are being recruited. The record has been updated to version v3.6.0, replacing the prior revision.
    Difference
    0.3%
    Check dated 2026-06-14T06:18:34.000Z thumbnail image

Stay in the know with updates to Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial page.